Long

Sorrento Announces Positive Preliminary Results of Phase 1b Stud

171
SRNE: Sorrento Therapeutics, Inc.
2021-01-26 19:09:38
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.